FindTrial
Sign In

Study for the molecular subtyping and pathogenesis of Glial Fibrillary Acidic Protein-IgG positive meningoencephalomyelitis

Study for the molecular subtyping and pathogenesis of Glial Fibrillary Acidic Protein-IgG positive meningoencephalomyelitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020767
Enrollment
Unknown
Registered
2019-01-19
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glial Fibrillary Acidic Protein-IgG positive meningoencephalitis

Interventions

Case series:N/A

Sponsors

Beijing Rehabilitation Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Encephalitis, Encephalopthy, Encephalomyelitis,Meningoencephalomyelitis; 2. the patients whose serum, cerebrospinal, or both GFPA-IgG are positive.

Exclusion criteria

Exclusion criteria: the patients whose serum and cerebrospinal GFAP-IgG are both negative will be excluded

Design outcomes

Primary

MeasureTime frame
subtype of GFAP-IgG;Antigen specific TCR;—

Countries

China

Contacts

Public ContactBoyan Fang

Beijing Rehabilitation Hospital of Capital Medical University

fangboyanv@163.com+86 18801086480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026